|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | C12N 15/62 | |
| A61K 48/00 | |||
| C12N 5/0783 | |||
| C12N 5/10 |
| (11) | Patento numeris | 3234144 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 15820739.9 |
| Europos patento paraiškos padavimo data | 2015-12-14 | |
| (97) | Europos patento paraiškos paskelbimo data | 2017-10-25 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2020-08-26 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (86) | Numeris | PCT/US2015/065629 |
| Data | 2015-12-14 |
| (87) | Numeris | WO 2016/100236 |
| Data | 2016-06-23 |
| (30) | Numeris | Data | Šalis |
| 201462092149 P | 2014-12-15 | US |
| (72) |
SPENCER, David, M., US
FOSTER, Aaron, Edward, US
BAYLE, Joseph, Henri, US
SLAWIN, Kevin, M., US
COLLINSON-PAUTZ, Matthew, R., US
|
| (73) |
Bellicum Pharmaceuticals, Inc.,
2130 West Holcombe Boulevard Ste. 850, Houston, TX 77030,
US
|
| (54) | METHODS FOR CONTROLLED ELIMINATION OF THERAPEUTIC CELLS |
| METHODS FOR CONTROLLED ELIMINATION OF THERAPEUTIC CELLS |